製品名:(E)-N'-(2-cyano-4-(3-(1-hydroxy-2-methylpropan-2-yl)thioureido)phenyl)-N,N-dimethylformimidamide

IUPAC Name:1-{3-cyano-4-[(E)-[(dimethylamino)methylidene]amino]phenyl}-3-(1-hydroxy-2-methylpropan-2-yl)thiourea

CAS番号:1429755-57-6
分子式:C15H21N5OS
純度:95%+
カタログ番号:CM329512
分子量:319.43

包装単位 有効在庫 価格(USD) 数量
CM329512-250g in stock ƩǭƏǎ
CM329512-500g in stock ĜŁĨŽ
CM329512-1000g in stock ƏţƩŁ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1429755-57-6
分子式:C15H21N5OS
融点:-
SMILESコード:CN(C)/C=N/C1=CC=C(NC(NC(C)(C)CO)=S)C=C1C#N
密度:
カタログ番号:CM329512
分子量:319.43
沸点:
MDL番号:
保管方法:Keep in a tight container and store at abient temperature

Column Infos

Tucatinib
In August 2023, phase III results for tyrosine kinase inhibitor Tukysa (tucatinib), in combination with antibody-drug conjugate Kadcyla (ado-trastuzumab emtansine), which met its primary endpoint of progression-free survival in HER-2 breast cancer patients.
TUKYSA (tucatinib) is an oral medicine that is a tyrosine kinase inhibitor of the HER2 protein. It is approved in more than 40 countries.